Both in Biotechnology
Curis vs Creative Medical Technology Holdings
Over the past year CRIS returned −98.5% and CELZ returned −87.1%; their daily moves had a correlation of -0.03.
CRIS −98.5% CELZ −87.1%Growth of $1, one year, split-adjusted
| Metric | CRIS | CELZ |
|---|---|---|
| Price | $0.4540 | $0.7200 |
| Market cap | $1.1M | $5.5M |
| Today | +12.79% | +4.32% |
| 1 month | −45.2% | −25.4% |
| 6 months | −96.0% | −67.6% |
| Year to date | −97.7% | −63.3% |
| 1 year | −98.5% | −86.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 1,822.2× |
| Net cash | $5.1M | $8.7M |
| Dividend yield | — | — |
| Volatility (60d) | 133.3% | 145.2% |
| Short % of float | 23.2% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).